BREAKUP PLANNED FOR AKZO NOBEL
Following three years of restructuring, Akzo Nobel is planning to split its pharmaceutical operations into a separate company. The Dutch company is preparing an initial public offering to sell a minority stake, the percentage still to be determined, in a new firm called Organon Biosciences. Akzo Nobel itself will remain a coatings and chemicals company.
Chemical & Engineering News (http://pubs.acs.org/cen/news/84/i07/8407notw4.html)